AzTrials
AzTrials

HalitosisNCT00867035

Bad Breath Response to Tongue Scraper and Rinses

A study testing Chlorine dioxide and scraper and Chlorhexidine gluconate and scraper in people with Halitosis, run by University of California, San Francisco at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Medical center personnel were screened organoleptically for bad breath by 2 investigators using Rosenberg scale 0-5, and measurement of breath sample in portable gas chromatograph. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Halitosis
What is being tested?
Chlorine dioxide and scraper and Chlorhexidine gluconate and scraper
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteUnited States
Study dates
Mar 2008to Jun 2009
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult with threshold score of 2 on organoleptic halitosis evaluation

Who cannot join

  • Taking another experimental drug, or antibiotic.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UCaliforniaSF

    San Francisco, California, 94143

Other trials in United States

About this study

Official title: Bad Breath Response to Tongue Scraper and Rinses, a Double-blind, Randomized, Parallel Group Clinical Trial.

Medical center personnel were screened organoleptically for bad breath by 2 investigators using Rosenberg scale 0-5, and measurement of breath sample in portable gas chromatograph. With a threshold score of 2 or more, or 75parts per billion(ppb) hydrogen sulfide(H2S), subjects invited to enter clinical trial of the mechanical effect of daily tongue scraping with the adjunctive use of 0.12% chlorhexidine gluconate mouthwash or 0.1% stabilized chlorine dioxide mouthwash. Subjects randomly assigned in double-blind trial for one week. The null hypothesis is there will be no difference between the two rinses as adjuncts to tongue scraping.

Read the detailed description

Subjects in trial had oral and periodontal exam and scored the Ramfjord teeth(#3, 9, 12, 19, 25, 28) for Plaque Index(PlI), Gingival Index(GI), probing depth (PD), recession. A tongue coating index is scored and sample of coating on dorsum taken for culture of total viable count and percentage of black sulfide-producing colonies on anaerobe agar with lead acetate added. Subjects given hygiene instruction and instruction on use of scraper, then rinse with 20ml assigned mouthwash 30sec. Breath assessed by organoleptic means and mouth air sample concentration of hydrogen sulfide, methyl mercaptan in portable gas chromatograph at 0, 1, 2, and 4 hours. Subjects use scraper and mouthwash twice daily for one week and return for final exam.

Conditions
Halitosis
Being tested
Chlorine dioxide and scraper, Chlorhexidine gluconate and scraper
Medical subject headings
Halitosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Chlorine dioxide and scraperDrug

    Also called "CloSYS"

    20ml of mouthwash used for 30sec as adjunct to tongue scraper twice a day

  • Chlorhexidine gluconate and scraperDrug

    Also called "Peridex"

    The intervention was accomplished by subject after instructions by investigator: twice a day the scraper was used for 4 strokes then 20ml 0.12% chlorhexidine gluconate rinse for 30sec, for one week.

Study groups in NCT00867035
Study groupRoleWhat they receive
Chlorhexidine gluconate and scraperActive comparatorThe intervention was accomplished by subject after instructions from investigator: twice a day a tongue scraper was used with 4 or more strokes, followed by 20ml of 0.12% chlorhexidine gluconate mouthwash used for 30 sec, for one week.
Receives: Drug: Chlorhexidine gluconate and scraper
Chlorine dioxide and scraperExperimentalThe intervention was accomplished by subject after instructions by investigator: twice a day the scraper was used for 4 strokes then 20ml 0.1% stabilized chlor8ine dioxide rinse for 30sec, for one week.
Receives: Drug: Chlorine dioxide and scraper

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Participants With Rosenberg Score at Indicated Time Points

    2 investigators are trained to evaluate smell using the Rosenberg scale which measures foul smelling breath. The Rosenberg scale is validated and is scored 0-5 with 0= no bad breath, 5=worst bad breath. A score of 2 is the threshold at which bad breath is determined.

    Measured: baseline, 1 hour, 2 hours, 4 hours, 1 week

Secondary outcomes (10)
  1. Concentration of Hydrogen Sulfide (H2S) in Mouth Air at 1 Hour

    Using portable gas chromatograph

    Measured: 1hr

  2. Concentration of Hydrogen Sulfide (H2S) in Mouth Air at 2 Hours

    Using portable gas chromatograph

    Measured: 2hr

  3. Concentration of Hydrogen Sulfide (H2S) in Mouth Air at 4 Hours

    Using portable gas chromatograph

    Measured: 4 hours

  4. Concentration of Hydrogen Sulfide (H2S) in Mouth Air at 1 Week

    Using portable gas chromatograph

    Measured: 1 week

  5. Concentration of Methyl Mercaptan (MM) in Mouth Air at 1 Hour

    Using portable gas chromatograph

    Measured: 1 hour

  6. Concentration of Methyl Mercaptan (MM) in Mouth Air at 2 Hours

    Using portable gas chromatograph

    Measured: 2 hours

  7. Concentration of Methyl Mercaptan (MM) in Mouth Air at 4 Hours

    Using portable gas chromatograph

    Measured: 4 hours

  8. Concentration of Methyl Mercaptan (MM) in Mouth Air at 1 Week

    Using portable gas chromatograph

    Measured: 1 week

  9. Number of Bacteria on Tongue at 1 Week

    Total viable count(TVC) in colony forming units(CFU) on anaerobe agar

    Measured: 1 week

  10. Percentage of Sulfide-producing Black Colonies Out of Total Viable Count(TVC) on Anaerobe Agar Containing Lead Acetate

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2009 (estimated)
  2. Study startMar 2008
  3. Primary completionMar 2009
  4. Study completionJun 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00867035
Sponsor's protocol ID
PGP1
Status last verified
May 2013
First submitted
20 Mar 2009
Last updated
16 May 2013
Data monitoring committee
Yes

Publications

  • Wirthlin MR, Im T, Ellis RR, Hoover CI. Effect of tongue scraper and rinses on bad breath, a double-blind, randomized, parallel group clinical trial. J West Soc Periodontol Periodontal Abstr. 2011;59(3):67-73. No abstract available.

    PubMed 22141237

Questions about this trial

What is this clinical trial studying?

A study testing Chlorine dioxide and scraper and Chlorhexidine gluconate and scraper in people with Halitosis, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 16 May 2013). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Participants With Rosenberg Score at Indicated Time Points (time frame: baseline, 1 hour, 2 hours, 4 hours, 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00867035, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in